Invuity, Inc. (IVTY) Shares Sold by Cowen Prime Services LLC
Cowen Prime Services LLC decreased its position in shares of Invuity, Inc. (NASDAQ:IVTY) by 2.7% during the third quarter, according to its most recent filing with the SEC. The firm owned 457,550 shares of the medical instruments supplier’s stock after selling 12,500 shares during the period. Invuity comprises about 1.9% of Cowen Prime Services LLC’s holdings, making the stock its 15th largest holding. Cowen Prime Services LLC owned about 2.67% of Invuity worth $4,072,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. CAPROCK Group Inc. grew its holdings in shares of Invuity by 28.6% during the 3rd quarter. CAPROCK Group Inc. now owns 45,000 shares of the medical instruments supplier’s stock worth $401,000 after acquiring an additional 10,000 shares during the period. OxFORD Asset Management LLP purchased a new stake in shares of Invuity in the 2nd quarter worth approximately $374,000. B. Riley Financial Inc. purchased a new stake in shares of Invuity in the 2nd quarter worth approximately $3,625,000. Royce & Associates LP grew its stake in shares of Invuity by 141.9% in the 2nd quarter. Royce & Associates LP now owns 98,939 shares of the medical instruments supplier’s stock worth $717,000 after buying an additional 58,033 shares during the last quarter. Finally, FMR LLC grew its stake in shares of Invuity by 0.5% in the 1st quarter. FMR LLC now owns 829,564 shares of the medical instruments supplier’s stock worth $6,595,000 after buying an additional 4,264 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/11/23/invuity-inc-ivty-shares-sold-by-cowen-prime-services-llc.html.
Several analysts recently weighed in on the company. Zacks Investment Research downgraded Invuity from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Northland Securities restated a “buy” rating and issued a $13.00 price target on shares of Invuity in a research note on Tuesday, September 26th. Piper Jaffray Companies restated a “buy” rating and issued a $10.00 price target on shares of Invuity in a research note on Wednesday, July 26th. Finally, ValuEngine upgraded Invuity from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $11.67.
Invuity (NASDAQ:IVTY) last posted its quarterly earnings results on Tuesday, November 7th. The medical instruments supplier reported ($0.52) earnings per share for the quarter, topping the consensus estimate of ($0.56) by $0.04. The company had revenue of $9.60 million for the quarter, compared to the consensus estimate of $9.87 million. Invuity had a negative return on equity of 212.38% and a negative net margin of 111.43%. analysts expect that Invuity, Inc. will post -2.41 EPS for the current fiscal year.
Invuity Company Profile
Invuity, Inc, a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges.
Want to see what other hedge funds are holding IVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invuity, Inc. (NASDAQ:IVTY).
Receive News & Stock Ratings for Invuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity Inc. and related stocks with our FREE daily email newsletter.